Dried blood on filter paper collected on the 5th day of life was used t o screen infants for CAH. A radioimmunoassay for 17-OHP without extraction with organic solvents was developed. The cut-off level was initially set a t 100 nmol/l blood based on analyses of stored blood spots from infants who were subsequently found to have CAH.
THE INTERPRETATION OF BLOODSPOT 1 7 4 -HYDROXYPROGES-TERONE LEVELS I N TERM AND PRETERM NEONATES
Plasma 1 7 d -Hydroxyprogesterone can vary considerably i n t h e f i r s t few days of l i f e . Bloodspot 174-hydroxyprogesterone. plasma c o r t i s o l , plasma sodium and urinary 17M-hydroxyproplesterone, c o r t i s o l , sodium and c r e a t i n i n e l e v e l s were determined i n 24 term and 31 preterm i n f a n t s on t h e t h i r d , eighth and fourteenth day of l i f e . R e t e r m i n f a n t s , whether 'well' o r ' s i c k ' had s i~n i f i c a n t l y r a i s e d bloodspot 17a-hydroyyprogesterone l e v e l s (up t o 158 nmol/l) compared with those found i n term s i c k o r well i n f a n t s (up t o 18.8 nmol/l).
Urinary 17d-hydroxyp r o~e s t e r o n e / c r e a t i n i n e r a t i o s were a l s o higher i n preterm i n f a n t s . Plasma c o r t i s o l r e s u l t s showed similar ranges f o r term and pre-term i n f a n t s , and bloodspot 17d-hydroxypro~esterone/ plasma c o r t i s o l r a t i o s f o r day 3 specimens c o r r e l a t e d with t h e degree of prematurity. These r e s u l t s may be due e i t h e r t o immature enzyme systems i n t h e preterm baby o r t o an excess of r e l a t e d s t e r o i d s cross-reactin6 i n t h e 17d-hydroxypro~esterone assay.
W e propose t h e use of two d i s t i n c t upper limits of normal of 20 nmol/l (term i n f a n t s ) and up t o MOnmol/l (preterm i n f a n t s ) f o r t h e i n t e r p r e t a t i o n of bloodspot 17Ol-hydroxypro~esterone l e v e l s a t t h e end of t h e f i r s t week of l i f e .
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The aim o f p r e n a t a l treatment o f CAH is prevention o f v i r i l iz a t i o n o f female f e t u s e s with 21 hydroxylase d e f i c i e n c y (21 CHd e f . ) . ltrs mthers a t r i s k f o r W were f o l l d during pregnancy, according to the plan: t r e a t m n t as e a r l y a s p o s s i b l e w i t h decadron 1 mg per day -transabdaninai chorion v i l l u s biopsy (at week 11) t o determine t h e sex -amniocentesis ( a t week 17) t o est a b l i s h (HIA t y p e s and s t e r o i d s ) i f the f e t u s is a f f e c t e d -continued treatnwt to b i r t h in a f f e c t e d girls. Case 1 (JIA) were treated f r a n 9 weeks o f pregnancy. The f e t u s turned o u t to be a boy, and trea-nt was stoppd. At b i r t h h e had n o s i g n s o f CAH ( n o r m 1 17 a -p r o g e s t e r o n e (1 7 OHP) , andrcstenedione (Adionel , t e s t o s t e r o n e , cortisol, A m , r e n i n ) .
Case 2 (FNO) was treated and s t u d i e d according t o the p l a n and the f e t u s was a g i r l , amniocentesis was p e r f o r m 4 and sh& raised v a l u e s f o r 17 OHP (30 m 1 / 1 ) , Adione (4 m l / l ) . She was HIAi d e n t i c a l to the a f f e c k d sister (A3B7/A3B47) and the treatment w i t h decadron (discontinued 5 days b e f o r e t h e amniocentesis) was continued to b i r t h . The a d r e n a l function o f the mther was t o t a ll y suppressed (urw c o r t i s o l < 20 m 1 / 2 4 h) , b u t normal a f t e r b i r t h . Study o f the g i r l a t day 1 and day 3 showed raised 17 OHP (172-123 m l / l ) , .3 m l / l ) , r e n i n (530-1824 pGU/ m l ) , ACPH (320 pg/ml) and low aldosterone (16-29 ng/lco m l ) . The external g e n i t a l i a showed a d e f i n i t i v e lesser v i r i l i z a t i o n (Prader s t a g e 1-2) by canparison w i t h the sister (Wader s t a g e 4). Marginal s a l t l o s s and hyperreninemia were previously reported i n p a t i e n t s with 11-OHD on glucocorticoid replacement (JCEM 58:384, 1984) . To evaluate t h e need f o r mineralocortic o i d therapy, 7 p a t i e n t s with 11-OHD, 5-14 y e a r s of age, were subjected t o 3 consecutive schedules of treatment: 1) 1 mglday dexamethasone (DEX) f o r 4 days, 2) 17 mg/m2/day hydrocortisone a c e t a t e (HC) f o r 4 days, and 3 ) HC and 0.1-0.2 mg/day 9a-fluorohydrocortisone (9ctF) The l a t t e r combination suppressed PRA, produced b e t t e r control of t h e pituitary-adrenal a x i s and enabled t h e use of a physiol o g i c dose of HC. PRA needs t o be monitored in 1 I-OHD p a t i e n t s ; when i t i s elevated, mineralocorticoid replacement i s indicated.
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CONGENITAL VIRILIZING ADRENALI-IYPERPLASIA (CVAH) DUE TO 21 HYDROXYLASE DEFICIENCY, RESULTS OF THERAPY \VITH CYPROTERONE ACETATE (CA).
Results obtained from t e n prepubertal p a t i e n t s ( 6 g i r l s , 4 boys) s u f f e r i n g of CVAH were compared over 12-41 months periods before and over 14-52 months periods during CA therapy (63 f 21 (SD)mg/m2/day). A t t h e beginning of treatment with CA, growth parameters were a s follow : chronological (Ch) ages .03 ( p < .05) respectively. When compared t o normal values f o r B ages, most plasma DHA values were normal before (9110) and during (7/10), most A4 androstenedione (A4A) values were elevated before (9110) and normal (9110) during CA treatment, while A4A/T r a t i o s increased s i g n i f i c a n t l y from 3.7 ' .32 t o 6.4 .96 ( p < .01). I n conclusion, CA appears t o be of i n t e r e s t i n t h e treatment of prepubertal p a t i e n t s with CVAH. The antiandrogenic e f f e c t is dernonst r a t e d by t h e improvement of bone maturation, t h e i n h i b i t i o n of ACTH production by t h e decreases i n 170HP l e v e l s . In a d d i t i o n t h e r e is evidence of a decrease i n t h e conversion r a t e s of adrenal androgens t o testosterone. One of t h e goals of glucocorticoid therapy i n c l a ss i c a l CAH I s t o s u r e s s excess andro en roduction t o revent remature e p i p h y s e 8 c l o s u r e and resuytdn! s h o r t s t a r u r e . ~l i s r e t r o s p e c t i v e s t d y was conducted t o determine i f t h e f i n d l height (FH) of 45 a d u l t p a t i e n t s ( p t s ) with CAH was inf!uenced by t h e c l i n i c a l v a r i a n t (salt-wdbting (SW) v! simple v i r i l i z i n g (SV)), age diaqnosis was made and treatment i n i t iated and-the degree of hormonal control. 6ood o r poor hormonal cont;ol were determined f r a n l e v e l s of 24 hr urinary 17-KS, s e r 9 ~4 -a n d r o s t e n e d i one (~4 -A ) and 17-OHP. The p a t i e n t was assigned t o t h e cdtegory of good c o~i t r o l i t n~ore than 50% of d a i l y urinary 17-KS o r serum ~4 -A wero normal f o r age (meank2SO o r i f 50% of t h e serum 17-OHP l e v e l s were < 1000 , , ng/dl. Ail others were assigned t o t h e poor control category; ., pts had i n s u f f i c i e n t d a t a f o r a s s i g m e n t . Final height was compared t o t h e mid-parental height (MPH t o t h e normal popul a t i o n , and t o 5 never t r e a t e d pts with h C A H The )dean f i n a l . H t , f o r a l l male p a t i e n t s was 163.2 cm ark f o r a l l female p a t i e n t s was 153.3 cm. Conclusion: The a d u l t height of 3 never t r e a t e d females was not d l t t e r e n t from anv t r e a t e d fe;dales. whether i n yood o r poor control. S W o r SV; o r t r e a t e d e a r l i o r l a t e . Among t h e t r e a t e d males, height wa5 not d i f f e r e n t whether they were in good o r poor c o n t r o l , S W o r SV, o r t r e a t d e a r l y o r l a t e . Althouqh t h e 2 never t r e a t e d males a r e s h o r t e r than t r e a t e d 111ales-t h e small number of t s recludes s t a t i s t ! c a l analysis. ~h 6 mean f i n a l heights 01 al! pts were s i m f i c a n t l y l e s s than t h e mean heights of males and females i n t 4 e normal population.
